Lonestar Medicines, Inc. funding

Lonestar Medicines, Inc., a biotechnology company based in Boston, MA (founded 2025), filed a Form D with the SEC on February 23, 2026 and reported $25M raised of a $45M offering.

Amount raised$25M

Offering size$45M

Filed with the SECFebruary 23, 2026

First saleJanuary 12, 2026

IndustryBiotechnology

SecuritiesEquity

LocationBoston, MA

Founded2025

Entity typeCorporation

Investors so far4

Minimum investment—

Revenue rangeDecline to Disclose

View the original Form D on SEC EDGAR ↗ · All rounds filed Feb 23

Other health care rounds in Massachusetts

Zai Lab Ltd$250M · Nov 9Biotechnology Typewriter Therapeutics, Inc.$56.3M · Sep 21Biotechnology AI3 Bio, Inc.$48.3M · Nov 4Biotechnology Nanopath Inc$29.9M · Nov 13Biotechnology XRHealth, Inc.$22.8M · Sep 16Other Health Care Xact Bio, Inc.$10M · Sep 28Biotechnology Crosslink Therapeutics Inc.$5.5M · Oct 20Pharmaceuticals Fresenius Medical Care Fulshear, LLC$4.4M · Oct 21Other Health Care